LIAISON® FT3 - COFEPRIS Registration 602R2019 SSA
Access comprehensive regulatory information for LIAISON® FT3 (FT3 LINK®) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 602R2019 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on March 26, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PARA LA DETERMINACIÓN CUANTITATIVA DE LA TRIYODOTIRONINA LIBRE (FT3) EN SUERO HUMANO Y PLASMA. LA PRUEBA DEBE REALIZARSE EN LA SERIE DE INSTRUMENTOS LIAISON® ANALYZER. AGENTE DE DIAGNÓSTICO PARA USO IN VITRO. PARA USO EXCLUSIVO DE LABORATORIOS CLÍNIC
FOR THE QUANTITATIVE DETERMINATION OF FREE TRIIODOTHYRONINE (FT3) IN HUMAN SERUM AND PLASMA. THE TEST SHOULD BE PERFORMED ON THE LIAISON® ANALYZER INSTRUMENT SERIES. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR THE EXCLUSIVE USE OF LABORATORIOS CLÍNIC